间歇性跛行患者胫动脉旁路术与不良结局相关
基于血管质量倡议(2003-2018)数据,比较间歇性跛行患者胫动脉与腘动脉旁路术的围术期及1年结局。胫动脉旁路术与更高的闭塞/死亡、同侧大截肢/死亡及再干预/截肢/死亡风险独立相关,患者生存率相似。
要点
- 胫动脉旁路术患者1年闭塞/死亡风险显著高于腘动脉旁路术(HR 1.65)。
- 胫动脉旁路术与同侧大截肢/死亡风险增加独立相关(HR 1.6)。
- 术前应充分尝试非手术治疗并向患者交代真实结局预期。
核心结论
- 在间歇性跛行患者中,胫动脉旁路术与不良结局相关,包括大截肢。
研究设计与样本
- 回顾性队列研究,查询血管质量倡议(2003-2018)中因间歇性跛行行腹股沟下旁路术的5347例患者。
主要发现
- 胫动脉旁路术1173例(22%),腘动脉旁路术4184例(78%)。
- 围术期胫动脉旁路术患者术后住院更长(4.5±3.5 vs 3.5±2.8天),肺部并发症更多(1.3% vs 0.6%),重返手术室更高(7% vs 4%),均P<.05。
- 1年时胫动脉旁路术患者免于闭塞/死亡(81% vs 89%)、免于同侧大截肢/死亡(90% vs 94%)、免于再干预/截肢/死亡(73% vs 80%)均更低,均P<.001。
- 多变量分析显示胫动脉旁路术独立与闭塞/死亡(HR 1.65;95%CI 1.28-2.11;P<.001)、同侧大截肢/死亡(HR 1.6;95%CI 1.12-2.19;P=.003)、同侧再干预/截肢/死亡(HR 1.51;95%CI 1.28-1.79;P<.001)风险增加相关。
临床怎么用
- 对于间歇性跛行患者,在考虑胫动脉旁路术前应充分尝试非手术治疗。
- 应向患者交代胫动脉旁路术的真实结局预期,包括大截肢风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Given that intermittent claudication (IC) rarely progresses to chronic limb-threatening ischemia and limb loss, safety and durability of elective interventions for IC are essential. Whether patients with IC benefit from tibial intervention is controversial, and data supporting its utility are limited. Despite endovascular therapy expansion, surgical bypass is still commonly performed. We sought to assess outcomes of bypass to tibial arteries for IC. METHODS: The Vascular Quality Initiative (2003-2018) was queried for infrainguinal bypasses performed for IC. Perioperative and 1-year outcomes were compared between bypasses constructed to tibial and popliteal arteries. RESULTS: Of 5347 infrainguinal bypasses, 1173 (22%) and 4184 (78%) were tibial and popliteal bypasses, respectively. Overall, mean age was 65 ± 10 years, and patients were often men (72%) and current smokers (42%). Tibial bypasses commonly targeted posterior tibial (40%), tibioperoneal trunk (23%), and anterior tibial (19%) arteries. Great saphenous vein was more often used for tibial bypass than for popliteal bypass (78% vs 54%; P < .001). Patients undergoing tibial compared with popliteal bypass more often had impaired ambulation and prior ipsilateral bypasses and were less often taking antiplatelets and statins (all P < .05). In the perioperative period, tibial bypass patients had longer postoperative length of stay (4.5 ± 3.5 vs 3.5 ± 2.8 days), more pulmonary complications (1.3% vs 0.6%), and higher return to the operating room (7% vs 4%; all P < .05). Perioperative myocardial infarction (1.2% vs 0.8%; P = .19), stroke (0.4% vs 0.4%; P = .91), and mortality (0.3 vs 0.3%; P = .86) rates were similar between the cohorts. At 1 year, tibial compared with popliteal bypasses exhibited lower freedom from occlusion/death (81% vs 89%; P < .001), ipsilateral major amputation/death (90% vs 94%; P < .001), and reintervention/amputation/death (73% vs 80%; P < .001), but patient survival was similar (96% vs 97%; P = .07). On multivariable analysis, tibial compared with popliteal bypass was independently associated with increased occlusion/death (hazard ratio [HR], 1.65; 95% confidence interval [CI], 1.28-2.11; P < .001), major ipsilateral amputation/death (HR, 1.6; 95% CI, 1.12-2.19; P = .003), and ipsilateral reintervention/amputation/death (HR, 1.51; 95% CI, 1.28-1.79; P < .001), with similar patient survival. CONCLUSIONS: In patients with IC, tibial bypass was associated with poor outcomes, including major amputation. Surgeons should exhaust nonoperative therapies and present realistic outcome expectations to their patients before offering such intervention.
引用
- Levin SR, Farber A, Osborne NH, et al. Tibial bypass in patients with intermittent claudication is associated with poor outcomes. J Vasc Surg. 2020. PMID: 32707381. doi:10.1016/j.jvs.2020.06.118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。